Top Markets
#1 Akedo Akedo +40.87%
#2 Bitway Bitway +23.95%
#3 Songbird Songbird +21.83%
#4 Astar Astar +18.95%
#5 AUKI AUKI +17.34%
#6 Falcon Finance Falcon Finance +14.58%
#7 Cross Cross +12.73%
#8 Nesa Nesa +8.50%
#9 VeThor VeThor +8.18%
#10 wojak wojak +7.87%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Classement en actions #94
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Prix de l'action
$44.39
Capitalisation boursière
$197.21B
Changement (1 jour)
-0.36%
Changement (1 an)
-20.45%
Pays
DK
Échange Novo Nordisk A/S (NOVO-B)

Catégorie

Healthcare
Ratio P/S pour Novo Nordisk A/S (NOVO-B)
Ratio P/S au January 2026 TTM : 5.21
Selon les derniers rapports financiers et le cours de l'action de Novo Nordisk A/S, le ratio cours/ventes actuel (TTM) est 5.21. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Novo Nordisk A/S de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
13.45 157.91%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.55 25.68%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.18 37.71%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
4.66 -10.67%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
5.39 3.31%
US